patent for semaglutide Your Questions Answered: Off-patent in 2026 Semaglutide's patent expires today. What

Its licenced and approved in the UK for both weight loss and weight management, which means that once youve reached your goal weight, you can continue to take it long-term to prevent weight regain

Craciun S, Balskus EP (2012) Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme

The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide both measured outcomes over 6872 weeks, and researchers have documented significant weight regain in patients who discontinue treatment prematurely

However, though in vivo, CAFs have been positive or negative for tumor growth, depending on the study